Organigram gets shareholder approval for Sanity Group purchase

Organigram Global's shareholders have approved the resolution required to consummate the previously announced acquisition by the company of Sanity Group GmbH and the related private placement financing with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco at the Company's annual general and special meeting of shareholders held on March 30, 2026.

As part of the proposed transaction, Sanity Group has been valued at a total of up to EUR 250 million, comprising an upfront EUR 130 million and up to EUR 120 million linked to defined performance metrics for twelve months ending March 31, 2027. Decisions regarding a future governance structure have deliberately not yet been made. "At present, our primary focus is on thoughtful integration and the creation of long-term value, rather than on rapid structural changes," explained Seyit Kaya, CFO of Sanity Group.